Squadron Capital Management LLC
Source: SEC Form 13F · as of Mar 2026Squadron Capital Management LLC holds 20 biotech & pharma companies tracked by BioSniper, totaling $171.6M in value as of Mar 2026 (SEC Form 13F).
Companies held
20
Total value held
$171.6M
| Company | Shares | Value |
|---|---|---|
| COGTCogent Biosciences, Inc. | 787,492 | $30.3M |
| KALVKalVista Pharmaceuticals, Inc. | 1,300,100 | $26.2M |
| KODKodiak Sciences Inc. | 380,000 | $14.5M |
| ABVXAbivax SA | 130,000 | $14.5M |
| EWTXEdgewise Therapeutics, Inc. | 350,000 | $11.0M |
| NKTRNEKTAR THERAPEUTICS | 125,000 | $9.0M |
| RLAYRelay Therapeutics, Inc. | 822,500 | $8.2M |
| MAZEMaze Therapeutics, Inc. | 257,500 | $7.7M |
| IDYAIDEAYA Biosciences, Inc. | 224,300 | $7.5M |
| CCCCC4 Therapeutics, Inc. | 2,250,000 | $5.9M |
| IKTInhibikase Therapeutics, Inc. | 3,500,000 | $5.9M |
| PALIPALISADE BIO, INC. | 3,000,000 | $5.3M |
| EPRXEUPRAXIA PHARMACEUTICALS INC. | 680,000 | $4.9M |
| GHRSGH Research PLC | 325,000 | $4.6M |
| KPTIKaryopharm Therapeutics Inc. | 750,000 | $4.2M |
| IVAInventiva S.A. | 535,000 | $3.0M |
| ALXOALX ONCOLOGY HOLDINGS INC | 1,460,000 | $2.9M |
| CNTXContext Therapeutics Inc. | 1,100,000 | $2.9M |
| AVBPArriVent BioPharma, Inc. | 110,000 | $2.5M |
| SPRBSPRUCE BIOSCIENCES, INC. | 12,200 | $797K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.